Skip to main content

Table 1 Patients, lesions and treatment characteristics

From: Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome

Patient features

Number of patients

% / (min – max)

Patients included in SiFEBI trial

 Yes

26

54.2

 No

22

45.8

 Mean age (years)

77.7

(65.2–92.3)

ECOG-Performans Status

 0

41

85.5

 1

7

14.5

 Tumor side

 Left

28

54.9

 Right

23

45.1

Location

 Upper external quadrant

20

39.2

 Upper internal quadrant

5

9.8

 Lower internal quadrant

3

5.9

 Lower external quadrant

3

5.9

 Junction of external quadrant

6

11.8

 Junction of internal quadrant

3

5.9

 Junction of lower quadrant

3

5.9

 Junction of upper quadrant

6

11.7

 Periareolar

2

3.9

 Median tumor size (mm)

12

(3–32)

Tumor stage

 T1a

28

54.9

 T1b

18

35.3

 T1c

5

9.8

Axillary lymph node status

 N0

46

90.1

 N1mic

4

7.9

 N1

1

2.0

Histology type

 Invasive ductal carcinoma

44

86.3

 Invasive lobular carcinoma

3

5.9

 Other

4

7.8

Histological grade

 1

32

62.7

 2

14

27.4

 3

5

9.8

Hormonal status

 Positive

48

94.1

 Negative

3

5.9

 Her-2 status

 Over-expressed

5

9.8

 Non-over-expressed

46

90.2

Peri-neural invasion

 Yes

1

1.9

 No

50

98.1

 Median Ki-67 (%)

10

(5–60)

 Median surg. Marg.(mm)

5

(1–10)

Implant time

 Intra operative

47

92.2

 Post-operative

4

7.8

 Median time interv. Surg./APBI (d)

7

(1–63)

 Median number of vectors

11

(5–15)

 Median number of planes

2

(1–3)

 Median CTV (cc)

44

(11–124)

 Median V100% (%)

96

(86–100)

 Median V150% (%)

34

(23–48)

 Median V200% (%)

12

(8–21)

 Median DNR

0.35

(0.23–0.56)

  1. Median time interv. Surg./APBI: median time between intervention and sfAPBI; Median surg. Marg.: median surgical margins; DNR: dose non-homogeneity ratio = V100/V150